CervoMed Inc. SEC filings CRVO
CervoMed Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 15, 1998. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 7, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 8, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 13, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 10, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 10, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 13, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 14, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 15, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 15, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 16, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 12, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 12, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 11, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 12, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 14, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 20, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 19, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 14, 2013 | Jun 30, 2013 |
| 10-Q/A | Amended quarterly report | May 20, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | May 17, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Nov 19, 2012 | Sep 30, 2012 |
| 10-Q/A | Amended quarterly report | Sep 7, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | Aug 17, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 21, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Nov 21, 2011 | Sep 30, 2011 |
| 10-Q | Quarterly report | Aug 16, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | May 17, 2011 | Mar 31, 2011 |
| 10-Q | Quarterly report | Nov 17, 2010 | Sep 30, 2010 |
| 10-Q/A | Amended quarterly report | Sep 1, 2010 | Mar 31, 2010 |
| 10-Q | Quarterly report | Aug 23, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 24, 2010 | Mar 31, 2010 |
| 10-Q | Quarterly report | Nov 19, 2009 | Sep 30, 2009 |
| 10-Q/A | Amended quarterly report | Nov 19, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | Aug 14, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | May 15, 2009 | Mar 31, 2009 |
| 10-Q/A | Amended quarterly report | Nov 20, 2008 | Oct 31, 2008 |
| 10-Q | Quarterly report | Nov 19, 2008 | Sep 30, 2008 |
| 10-Q | Quarterly report | Aug 29, 2008 | Jun 30, 2008 |
| 10-Q | Quarterly report | Aug 29, 2008 | Mar 31, 2008 |
| 10-Q | Quarterly report | Nov 20, 2000 | Sep 30, 2000 |
| 10-Q/A | Amended quarterly report | Sep 12, 2000 | Jul 1, 2000 |
| 10-Q | Quarterly report | Aug 21, 2000 | Jul 1, 2000 |
| 10-Q/A | Amended quarterly report | Aug 21, 2000 | Apr 1, 2000 |
| 10-Q | Quarterly report | May 15, 2000 | Apr 1, 2000 |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRVO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1053691
- Former names
- Diffusion Pharmaceuticals Inc. (until Aug 14, 2023); RestorGenex Corp (until Jan 14, 2016); Stratus Media Group, Inc (until Mar 7, 2014); FERIS INTERNATIONAL, INC. (until Jul 16, 2008); TITAN MOTORCYCLE CO OF AMERICA INC (until Feb 22, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.